FrancophonIA/ELRC3.0 huggingface dataset:
English: • The recommended usual daily dose is Exelon 9.5 mg/24 h. If well tolerated, the treating physician may consider increasing the dose to 13.3 mg/24 h.
Slovenian: • Priporočeni običajni dnevni odmerek zdravila Exelon je 9,5 mg/24 h. Če ta odmerek dobro prenašate, lahko lečeči zdravnik razmisli o zvišanju odmerka na 13,3 mg/24 h.
English: Like all medicines, Exelon transdermal patches can cause side effects, although not everybody gets them.
Slovenian: Kot vsa zdravila imajo lahko tudi transdermalni obliži Exelon neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
English: Exelon may cause dizziness and somnolence, mainly at the start of treatment or when increasing the dose.
Slovenian: Zdravilo Exelon lahko povzroči vrtoglavost in zaspanost, predvsem na začetku zdravljenja ali ob povečanju odmerka.
English: If this applies to you, tell your doctor and do not apply Exelon transdermal patches.
Slovenian: Če kaj od navedenega velja za vas, povejte svojemu zdravniku in ne uporabljajte transdermalnih obližev Exelon.
English: Table 2 shows the adverse reactions reported during clinical studies conducted in patients with dementia associated with Parkinson's disease treated with Exelon capsules.
Slovenian: Preglednica 2 prikazuje neželene učinke, o katerih so poročali iz kliničnih študij, ki so jih izvajali pri bolnikih z demenco, povezano s Parkinsonovo boleznijo, zdravljenih s kapsulami zdravila Exelon.
English: Exelon might interfere with anticholinergic medicines (medicines used to relieve stomach cramps or spasms, to treat Parkinson's disease or to prevent travel sickness).
Slovenian: Zdravilo Exelon bi lahko vplivalo na zdravljenje z antiholinergičnimi zdravili (zdravili, ki se uporabljajo za lajšanje želodčnih krčev ali spazmov, za zdravljenje Parkinsonove bolezni ali za preprečevanje slabosti na potovanju).
English: The European Medicines Agency has waived the obligation to submit the results of studies with Exelon in all subsets of the paediatric population in the treatment of Alzheimer's dementia (see section 4.2 for information on paediatric use).
Slovenian: Evropska agencija za zdravila je odstopila od zahteve za predložitev rezultatov študij z zdravilom Exelon za vse podskupine pediatrične populacije glede zdravljenja Alzheimerjeve demence (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
English: Multipack: 60 (2 packs of 30) transdermal patches Multipack: 90 (3 packs of 30) transdermal patches Multipack: 84 (2 packs of 42) transdermal patches
Slovenian: Skupno pakiranje: 60 (2 pakiranji po 30) transdermalnih obližev Skupno pakiranje: 90 (3 pakiranja po 30) transdermalnih obližev Skupno pakiranje: 84 (2 pakiranji po 42) transdermalnih obližev
English: If this applies to you, tell your doctor and do not take Exelon.
Slovenian: Če kaj od navedenega velja za vas, povejte svojemu zdravniku in ne jemljite zdravila Exelon.
English: This may indicate a potential for Exelon transdermal patches to induce mild erythema in patients.
Slovenian: To lahko nakazuje možnost, da bi transdermalni obliži Exelon sprožili nastanek blage rdečine pri bolnikih.
English: If you accidentally apply more than one patch, remove all the patches from your skin, then inform your doctor that you have accidentally applied more than one patch.
Slovenian: Če ste uporabili večji odmerek zdravila Exelon, kot bi smeli Če ste nehote namestili več kot en obliž, odstranite s kože vse obliže in obvestite zdravnika, da ste nehote namestili več kot en obliž.
English: If you have to undergo surgery whilst using Exelon transdermal patches, tell your doctor that you are using them because they may exaggerate the effects of some muscle relaxants during anaesthesia.
Slovenian: Če morate v času uporabe transdermalnih obližev Exelon na operacijo, morate obvestiti zdravnika, da jih uporabljate, ker lahko med anestezijo povečajo učinke nekaterih mišičnih relaksantov.
English: Table 1 displays the adverse reactions reported in 1,670 patients with Alzheimer's dementia treated in randomised, double-blind, placebo and active-controlled clinical studies with Exelon transdermal patches for a duration of 24-48 weeks and from post-marketing data.
Slovenian: V preglednici 1 so navedeni neželeni učinki o katerih so poročali pri 1.670 bolnikih z Alzheimerjevo demenco, zdravljenih v okviru randomiziranih dvojno slepih, s placebom in aktivno kontroliranih kliničnih študij s transdermalnimi obliži Exelon, ki so trajale od 24 do 48 tednov, in neželeni učinki po podatkih iz obdobja trženja zdravila.
English: Exelon 2 mg/ml [folding box only]
Slovenian: Exelon 2 mg/ml [samo na škatli]
English: • Treatment usually starts with Exelon 4.6 mg/24 h.
Slovenian: • Zdravljenje se običajno začne z obližem Exelon 4,6 mg/24 h.
English: If you accidentally take more Exelon than you should, inform your doctor.
Slovenian: Če ste vzeli večji odmerek zdravila Exelon, kot bi smeli Če nehote vzamete več zdravila Exelon, kot bi smeli, obvestite svojega zdravnika.
English: By blocking these enzymes, Exelon allows levels of acetylcholine to be increased in the brain, helping to reduce the symptoms of Alzheimer's disease.
Slovenian: Zdravilo Exelon z zaviranjem navedenih encimov omogoča zvišanje koncentracije acetilholina v možganih in s tem pomaga pri zmanjševanju simptomov Alzheimerjeve bolezni.
English: The European Medicines Agency has waived the obligation to submit the results of studies with Exelon in all subsets of the paediatric population in the treatment of Alzheimer's dementia and in the treatment of dementia in patients with idiopathic Parkinson's disease (see section 4.2 for information on paediatric use).
Slovenian: Evropska agencija za zdravila je odstopila od zahteve za predložitev rezultatov študij z zdravilom Exelon za vse podskupine pediatrične populacije glede zdravljenja Alzheimerjeve demence in zdravljenja demence pri bolnikih z idiopatsko Parkinsonovo boleznijo (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
English: Exelon capsules 12 mg/day
Slovenian: Exelon kapsule 12 mg/dan
English: The incidence of application site skin reactions leading to discontinuation was ≤2.3% in patients treated with Exelon transdermal patches.
Slovenian: Do reakcij na mestu aplikacije, zaradi katerih je bilo treba zdravljenje prekiniti, je prišlo pri ≤2,3 % bolnikov, ki so se zdravili s transdermalnimi obliži Exelon.
English: The following additional adverse reaction has been observed in a study of patients with dementia associated with Parkinson's disease treated with Exelon transdermal patches: agitation (common).
Slovenian: Naslednji neželeni učinek so, poleg že navedenih, opažali v študiji pri bolnikih, ki so imeli demenco v povezavi s Parkinsonovo boleznijo in so bili zdravljeni s transdermalnimi obliži Exelon: agitiranost (pogosti).
English: Talk to your doctor before using Exelon: - if you have, or have ever had, an irregular or slow heartbeat.
Slovenian: Pred začetkom jemanja zdravila Exelon se posvetujte z zdravnikom: - če imate ali če ste kdaj imeli nepravilen ali počasen srčni utrip, - če imate ali če ste kdaj imeli aktivno želodčno razjedo,
English: Exelon contains sodium benzoate
Slovenian: Zdravilo Exelon vsebuje natrijev benzoat
English: Gently pull at one edge of the patch to remove it slowly from the skin.
Slovenian: Nežno povlecite za en rob obliža in nato obliž počasi odstranite.
English: The fluctuation index (FI), a measure of the relative difference between peak and trough concentrations ((Cmax-Cmin)/Cavg), was 0.58 for Exelon 4.6 mg/24 h transdermal patches, 0.77 for Exelon 9.5 mg/24 h transdermal patches and 0.72 for Exelon 13.3 mg/24 h transdermal patches, thus demonstrating a much smaller fluctuation between trough and peak concentrations than for the oral formulation (FI = 3.96 (6 mg/day) and 4.15 (12 mg/day)).
Slovenian: Fluktuacijski indeks(FI), ki izraža relativno razliko med najvišjimi in najnižjimi koncentracijami ((Cmax-Cmin)/Cavg; pri tem je Cavg povprečna koncentracija v obdobju odmerjanja), je bil 0,58 pri transdermalnih obližih Exelon 4,6 mg/24 h, 0,77 pri transdermalnih obližih Exelon 9,5 mg/24 h in 0,72 pri transdermalnih obližih Exelon 13,3 mg/24 h, kar kaže na veliko manjšo fluktuacijo od najnižjih do najvišjih koncentracij kot pri peroralnem odmerjanju (FI = 3,96 za odmerjanje 6 mg/dan in 4,15 za odmerjanje 12 mg/dan).
English: Exelon oral solution should be used within 1 month of opening the bottle.
Slovenian: Peroralno raztopino Exelon je treba porabiti v enem mesecu po prvem odprtju steklenice.
English: For patients starting treatment for the first time and for patients restarting Exelon after treatment interruption, please begin with the second picture.
Slovenian: Bolniki, ki si prvič nameščate obliž ali ponovno začenjate z uporabo zdravila Exelon po prekinitvi zdravljenja, lahko začnete z naslednjim korakom.
English: The following adverse reactions, listed below in Table 1, have been accumulated in patients with Alzheimer's dementia treated with Exelon.
Slovenian: Neželene učinke, navedene v spodnji preglednici 1, so zbrali pri bolnikih z Alzheimerjevo demenco, zdravljenih z zdravilom Exelon.
English: The efficacy of Exelon transdermal patches in patients with Alzheimer's dementia has been demonstrated in a 24-week double-blind, placebo-controlled core study and its open-label extension phase and in a 48-week double-blind comparator study.
Slovenian: Učinkovitost transdermalnih obližev Exelon pri bolnikih z Alzheimerjevo demenco so dokazali v 24-tedenski dvojno slepi, s placebom kontrolirani osnovni študiji in njenem odprtem podaljšku ter v 48-tedenski dvojno slepi primerjalni študiji.
English: If you have to undergo surgery whilst taking Exelon, tell your doctor before you are given any anaesthetics, because Exelon may exaggerate the effects of some muscle relaxants during anaesthesia.
Slovenian: Če morate v času jemanja zdravila Exelon na operacijo, povejte zdravniku, da jemljete zdravilo Exelon, preden dobite kakršnokoli anestezijo, ker lahko zdravilo Exelon med anestezijo poveča učinke nekaterih mišičnih relaksantov.
English: When observed in patients treated with Exelon transdermal patches, skin irritation was mostly slight or mild in severity.
Slovenian: Pri bolnikih, ki so se zdravili s transdermalnimi obliži Exelon, so večinoma opažali le rahlo ali blago izraženo vnetje.
English: Available in packs containing 7, 30 or 42 sachets and in multipacks containing 60, 84 or 90 sachets.
Slovenian: Na voljo so v pakiranju, ki vsebuje 7, 30 ali 42 vrečk, in v skupnem pakiranju, ki vsebuje 60, 84 ali 90 vrečk.
English: By blocking these enzymes, Exelon allows levels of acetylcholine to be increased in the brain, helping to reduce the symptoms of Alzheimer's disease and dementia associated with Parkinson's disease.
Slovenian: Zdravilo Exelon z zaviranjem navedenih encimov omogoča zvišanje koncentracije acetilholina v možganih in s tem pomaga pri zmanjševanju simptomov Alzheimerjeve bolezni in demence v povezavi s Parkinsonovo boleznijo.
English: • Paediatric population: There is no relevant use of Exelon in the paediatric population in the treatment of Alzheimer's disease.
Slovenian: • Pediatrična populacija: Zdravilo Exelon ni namenjeno za uporabo pri pediatrični populaciji za zdravljenje Alzheimerjeve bolezni.
English: Particular caution must be exercised in titrating these patients (see sections 4.2 and 5.2).
Slovenian: Pri titriranju odmerka tem bolnikom je potrebna posebna previdnost (glejte poglavji 4.2 in 5.2).
English: • The signs of Parkinson's disease get worse or getting similar signs - such as stiff muscles, difficulty in carrying out movements and muscle weakness
Slovenian: • poslabšanje znakov Parkinsonove bolezni ali pojav podobnih znakov - na primer togih mišic ali težav pri izvajanju gibov in mišične šibkosti
English: EXP Use Exelon oral solution within 1 month of opening the bottle.
Slovenian: EXP Peroralno raztopino Exelon porabite v 1 mesecu po prvem odprtju steklenice.
English: • Use Exelon oral solution within 1 month of opening the bottle.
Slovenian: • Peroralno raztopino Exelon porabite v 1 mesecu po prvem odprtju steklenice.
English: Contact with the eyes should be avoided after handling Exelon transdermal patches (see section 5.3).
Slovenian: Po rokovanju s transdermalnimi obliži Exelon se ne sme dotikati oči (glejte poglavje 5.3).
English: Rivastigmine was not mutagenic in a standard battery of in vitro and in vivo tests, except in a chromosomal aberration test in human peripheral lymphocytes at a dose exceeding 10
Slovenian: V standardni bateriji testov in vitro in in vivo rivastigmin ni bil mutagen, razen v testu kromosomskih aberacij v človeških perifernih levkocitih v odmerku, ki je 10
English: If you forget to use Exelon
Slovenian: Če ste pozabili uporabiti zdravilo Exelon
English: The following adverse reactions have only been observed with Exelon capsules and oral solution and not in clinical studies with Exelon transdermal patches: malaise, confusion, sweating increased (common); duodenal ulcers, angina pectoris (rare); gastrointestinal haemorrhage (very rare); and some cases of severe vomiting were associated with oesophageal rupture (not known).
Slovenian: Naslednje neželene učinke so opažali samo pri uporabi kapsul in peroralne raztopine Exelon, ne pa v kliničnih študijah s transdermalnimi obliži Exelon: splošno slabo počutje, zmedenost, povečano potenje (pogosto); razjede dvanajstnika, angino pektoris (redko); krvavitev v prebavila (zelo redko); in nekaj primerov hudega bruhanja, ki je bilo povezano z rupturo požiralnika (pogostnost neznana).
English: The outer layer is beige and labelled with the following: - “Exelon”, “4.6 mg/24 h” and “AMCX”, - “Exelon”, “9.5 mg/24 h” and “BHDI”, - “Exelon”, “13.3 mg/24 h” and “CNFU”.
Slovenian: Zunanja plast je rjavkasto bele barve z eno od naslednjih oznak: - “Exelon”, “4.6 mg/24 h” in “AMCX”, - “Exelon”, “9.5 mg/24 h” in “BHDI”, - “Exelon”, “13.3 mg/24 h” in “CNFU”.
English: Exelon 13.3 mg/24 h transdermal patches are available in packs containing 7 or 30 sachets and in multipacks containing 60 or 90 sachets.
Slovenian: Zdravilo Exelon 13,3 mg/24 h transdermalni obliž je na voljo v pakiranju, ki vsebuje 7 ali 30 vrečk in v skupnem pakiranju, ki vsebuje 60 ali 90 vrečk.
English: Exelon 4.6 mg/24 h transdermal patches and Exelon 9.5 mg/24 h transdermal patches are available in packs containing 7, 30 or 42 sachets and in multipacks containing 60, 84 or 90 sachets.
Slovenian: Zdravili Exelon 4,6 mg/24 h transdermalni obliž in Exelon 9,5 mg/24 h transdermalni obliž sta na voljo v pakiranju, ki vsebuje 7, 30 ali 42 vrečk in v skupnem pakiranju, ki vsebuje 60, 84 ali 90 vrečk.
English: As rivastigmine has a plasma half-life of about 3.4 hours and a duration of acetylcholinesterase inhibition of about 9 hours, it is recommended that in cases of asymptomatic overdose all Exelon transdermal patches should be removed immediately and no further transdermal patch should be applied for the next 24 hours.
Slovenian: Ker ima rivastigmin plazemski razpolovni čas okrog 3,4 ure in trajanje zaviranja acetilholinesteraze okrog 9 ur, v primeru asimptomatičnega prevelikega odmerka priporočamo takojšnjo odstranitev vseh transdermalnih obližev Exelon.
English: One of the inactive ingredients in Exelon oral solution is sodium benzoate.
Slovenian: Ena od neaktivnih sestavin peroralne raztopine Exelon je natrijev benzoat.
English: What Exelon is and what it is used for What you need to know before you use Exelon How to use Exelon
Slovenian: Kaj je zdravilo Exelon in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo Exelon Kako uporabljati zdravilo Exelon Možni neželeni učinki
English: Patients with severe hepatic impairment have not been studied, however, Exelon capsules may be used in this patient population provided close monitoring is exercised (see sections 4.4 and 5.2).
Slovenian: Uporabe zdravila pri bolnikih s težko jetrno okvaro niso proučili, bolniki iz te populacije lahko kljub temu uporabljajo zdravilo Exelon v obliki kapsul, vendar jih je treba skrbno spremljati (glejte poglavji 4.4 in 5.2).
English: If you forget to take Exelon
Slovenian: Če ste pozabili vzeti zdravilo Exelon
English: Overdose with Exelon transdermal patch resulting from misuse/dosing errors (application of multiple patches at a time) has been reported in the post-marketing setting and rarely in clinical trials.
Slovenian: V obdobju trženja zdravila so poročali o prevelikem odmerjanju s transdermalnimi obliži Exelon, do česar je prišlo zaradi nepravilne uporabe/odmerjanja (nameščenih več obližev hkrati), v kliničnih študijah pa so o takih primerih poročali le redko.
English: Exelon 1.5 mg hard capsules Exelon 3.0 mg hard capsules Exelon 4.5 mg hard capsules Exelon 6.0 mg hard capsules
Slovenian: Exelon 1,5 mg trde kapsule Exelon 3,0 mg trde kapsule Exelon 4,5 mg trde kapsule Exelon 6,0 mg trde kapsule
English: • Hepatic impairment: Due to increased exposure in mild to moderate hepatic impairment as observed with the oral formulation, dosing recommendations to titrate according to individual tolerability should be closely followed.
Slovenian: Zaradi povečane izpostavljenosti zdravilu pri blagi do zmerni okvari jeter, kar so opažali pri uporabi peroralnih oblik zdravila, se je treba natančno ravnati po priporočilih, naj se odmerjanje titrira glede na individualno prenašanje.
English: If you are pregnant, the benefits of using Exelon must be assessed against the possible effects on your unborn child. Exelon should not be used during pregnancy unless clearly necessary.
Slovenian: V primeru, da ste noseči, je treba pretehtati koristi uporabe zdravila Exelon in možne učinke na nerojenega otroka.
English: 7 transdermal patches 30 transdermal patches 42 transdermal patches
Slovenian: 7 transdermalnih obližev 30 transdermalnih obližev 42 transdermalnih obližev
English: What you need to know before you use Exelon
Slovenian: Kaj morate vedeti, preden boste uporabili zdravilo Exelon
English: The following additional adverse reactions have been observed with Exelon transdermal patches: delirium, pyrexia, decreased appetite, urinary incontinence (common), psychomotor hyperactivity (uncommon), erythema, urticaria, vesicles, allergic dermatitis (not known).
Slovenian: Pri uporabi transdermalnih obližev Exelon so dodatno opažali še naslednje neželene učinke: delirij, zvišano telesno temperaturo, zmanjšan apetit, urinska inkontinenca (pogosto), psihomotorična hiperaktivnost (občasno), eritem, urtikarija, mehurčki, alergijski dermatitis (pogostnost neznana).
English: Exelon transdermal patches 9.5 mg/24 h N = 251
Slovenian: Exelon transdermalni obliži 9,5 mg/24 h N = 251
English: In pregnant animals, rivastigmine and /or metabolites crossed the placenta.
Slovenian: Pri brejih živalih so rivastigmin in/ali njegovi presnovki prehajali skozi posteljico.
English: What Exelon is and what it is used for What you need to know before you take Exelon How to take Exelon
Slovenian: Kaj je zdravilo Exelon in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Exelon Kako jemati zdravilo Exelon Možni neželeni učinki
English: Patients with severe hepatic impairment have not been studied, however, Exelon oral solution may be used in this patient population provided close monitoring is exercised (see sections 4.4 and 5.2).
Slovenian: Uporabe zdravila pri bolnikih s težko jetrno okvaro niso proučili, bolniki iz te populacije lahko kljub temu uporabljajo zdravilo Exelon peroralno raztopino, vendar jih je treba skrbno spremljati (glejte poglavji 4.4 in 5.2).
English: What you need to know before you take Exelon
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo Exelon
English: What Exelon looks like and contents of the pack Exelon oral solution is supplied as 50 ml or 120 ml of a clear, yellow solution (2.0 mg/ml base) in an amber glass bottle with a child-resistant cap, foam liner, dip tube and self aligning plug.
Slovenian: Peroralna raztopina Exelon je na voljo v obliki 50 ml ali 120 ml bistre rumene raztopine (2,0 mg/ml baze), v jantarno obarvani steklenici z za otroke varno zaporko, oblogo iz penaste gume, s kapalnim vložkom in s prilegajočim se zamaškom.
English: What Exelon contains - The active substance is rivastigmine.
Slovenian: Kaj vsebuje zdravilo Exelon - Učinkovina je rivastigmin.
English: There is no relevant use of Exelon in the paediatric population in the treatment of Alzheimer's disease.
Slovenian: Zdravila Exelon ni smiselno uporabljati pri pediatrični populaciji za zdravljenje Alzheimerjeve bolezni.
English: Each Exelon 6.0 mg capsule contains 6.0 mg of rivastigmine.
Slovenian: Vsaka kapsula Exelon 6,0 mg vsebuje 6,0 mg rivastigmina.
English: Each Exelon 1.5 mg capsule contains 1.5 mg of rivastigmine.
Slovenian: Vsaka kapsula Exelon 1,5 mg vsebuje 1,5 mg rivastigmina.
English: You should not breast-feed during treatment with Exelon transdermal patches.
Slovenian: Med zdravljenjem s transdermalnimi obliži Exelon ne smete dojiti.
English: What Exelon contains - The active substance is rivastigmine hydrogen tartrate.
Slovenian: Kaj vsebuje zdravilo Exelon - Učinkovina je rivastigminijev hidrogentartrat.
English: Other side effects seen with Exelon capsules or oral solution and which may occur with the patch:
Slovenian: Drugi neželeni učinki, ki so jih opažali pri uporabi kapsul ali peroralne raztopine Exelon in bi se lahko pojavili tudi pri uporabi obližev:
English: Transdermal patches Rivastigmine in vivo release rates per 24 h
Slovenian: Odmerjanje transdermalni obliži hitrost sproščanja rivastigmina na 24 ur in vivo
English: The outside of the backing layer is beige and labelled with “Exelon”, “4.6 mg/24 h” and “AMCX”.
Slovenian: Zunanji del krovne plasti je rjavkasto bele (beige) barve z oznakami “Exelon”, “4.6 mg/24 h” in “AMCX”.
English: What Exelon looks like and contents of the pack - Exelon 1.5 mg hard capsules, which contain an off-white to slightly yellow powder, have a yellow cap and yellow body, with red imprint “EXELON 1,5 mg” on the body.
Slovenian: Izgled zdravila Exelon in vsebina pakiranja - Exelon 1,5 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo rumen pokrovček in rumeno telo kapsule z rdečim napisom “EXELON 1,5 mg”.
English: - Exelon 4.6 mg/24 h transdermal patches: Each patch releasing 4.6 mg of rivastigmine per 24 hours is 5 cm and contains 9 mg of rivastigmine.
Slovenian: - Exelon 4,6 mg/24 h transdermalni obliži: vsak obliž, ki sprosti 4,6 mg rivastigmina na 24 ur, je velik 5 cm in vsebuje 9 mg rivastigmina.
English: The active substance of Exelon is rivastigmine.
Slovenian: Zdravilna učinkovina v zdravilu Exelon je rivastigmin.
English: - Exelon 9.5 mg/24 h transdermal patches: Each patch releasing 9.5 mg of rivastigmine per 24 hours is 10 cm and contains 18 mg of rivastigmine.
Slovenian: - Exelon 9,5 mg/24 h transdermalni obliži: vsak obliž, ki sprosti 9,5 mg rivastigmina na 24 ur, je velik 10 cm in vsebuje 18 mg rivastigmina.
English: Exelon 1.5 mg hard capsules Exelon 3.0 mg hard capsules Exelon 4.5 mg hard capsules Exelon 6.0 mg hard capsules rivastigmine
Slovenian: Exelon 1,5 mg trde kapsule Exelon 3,0 mg trde kapsule Exelon 4,5 mg trde kapsule Exelon 6,0 mg trde kapsule rivastigmin
English: One of the excipients in Exelon oral solution is sodium benzoate.
Slovenian: Ena od pomožnih snovi peroralne raztopine Exelon je natrijev benzoat.
English: Although less pronounced than with the oral formulation, exposure to rivastigmine (Cmax and AUC) increased over-proportionally by a factor of 2.6 and 4.9 when escalating from 4.6 mg/24 h to 9.5 mg/24 h and to 13.3 mg/24 h, respectively.
Slovenian: Čeprav manj izrazito kot pri peroralnem odmerjanju, se je pri stopnjevanju z odmerka 4,6 mg/24 h na 9,5 mg/24 h oziroma na 13,3 mg/24 h izpostavljenost rivastigminu (Cmax in